NCT02461550View on ClinicalTrials.gov

Irreversible Electroporation Ablation for Colorectal Metastases to the Lung

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Colorectal Metastases to the Lung
Interventions
DEVICE

Irreversible Electroporation Ablation

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering West Harrison, Harrison

11725

Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack

07920

Memorial Sloan-Kettering at Basking Ridge, Basking Ridge

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02461550 - Irreversible Electroporation Ablation for Colorectal Metastases to the Lung | Biotech Hunter | Biotech Hunter